Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.69 +0.04 (+1.10%)
As of: Sep 30, 2026 · 10:22 AM EDT

Bicycle Therapeutics (BCYC) EBIT Margin (2018 - 2026)

Updated

Bicycle Therapeutics (BCYC) reported EBIT Margin of -8673.93% for Q2 2026, down 5708.10 percentage points from -2965.82% a year earlier and down 1291.51 percentage points from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) EBIT Margin (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bicycle Therapeutics' EBIT Margin came in at -343.60%, up 1151.73 percentage points year-over-year; for FY2025, it was -340.38%, up 254.58 percentage points from FY2024.

  • EBIT Margin has increased for three consecutive years, with a five-year change of +159.72 percentage points (FY2020 to FY2025).
  • By year, EBIT Margin came in at -594.96% in FY2024 (+109.17 pp), -704.13% in FY2023 (+102.43 pp), -806.56% in FY2022 (-245.58 pp) and -560.98% in FY2021 (-60.89 pp).
  • The Q2 2026 figure ranks as the lowest quarterly EBIT Margin in data going back to Q1 2018.
  • Year over year, EBIT Margin gained in two of the last eight quarters, with an average year-over-year change of -1754.92 percentage points.
  • The high point for year-over-year EBIT Margin in five years was Q3 2025 (a gain of 1827.23 percentage points); the low point was Q1 2026 (a drop of 6678.75 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -7382.41% (Q1 2026), -51.52% (Q4 2025) and -558.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Bicycle Therapeutics 259.01 Mn 259.01 Mn - -8,673.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,673.93%
Mar 31, 2026 -7,382.41%
Dec 31, 2025 -51.52%
Sep 30, 2025 -558.64%
Jun 30, 2025 -2,965.82%
Mar 31, 2025 -703.66%
Dec 31, 2024 -1,824.78%
Sep 30, 2024 -2,385.87%
Jun 30, 2024 -498.31%
Mar 31, 2024 -162.40%
Dec 31, 2023 -1,017.35%
Sep 30, 2023 -949.12%
Jun 30, 2023 -378.27%
Mar 31, 2023 -853.82%
Dec 31, 2022 -1,011.33%
Sep 30, 2022 -978.91%
Jun 30, 2022 -623.57%
Mar 31, 2022 -709.40%
Dec 31, 2021 -477.96%
Sep 30, 2021 -329.89%
API Access

Bicycle Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=BCYC&period=max&api_key=YOUR_API_KEY